Role of activator protein-1 in TCR-mediated regulation of the murine fasl promoter

Journal of Immunology

Volumn 164, Issue 6, 2000, Pages 3002-3008

  Matsui, Ken ^a   Xiao, Sheng ^b   Fine, Alan ^a   Ju, Shyr Te ^a,b  

^a Arthritis Center   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE I; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR AP 1;

ARTICLE; DNA FOOTPRINTING; GENE CONTROL; GENETIC TRANSFECTION; MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 0034654543     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.6.3002     Document Type: Article

References (51)

1. Watanabe-Fukunaga, R., C. I. Grannan, N. Itoh, S. Yonehara, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148:1274.
2. Miyawaki, T., T. Uehara, R. Nibu, T. Tsuji, A. Yachie, S. Yonehara, and N. Taniguchi. 1992. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J. Immunol. 149:3753.
3. 2+-independent T-cell-mediated cytotoxicity. J. Exp. Med. 177:195.
4. Suda, T., T. Takahashi, P. Goldstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169.
5. Arase, H., N. Arase, and T. Saito. 1995. Fas mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med. 181:1235.
6. Bellgrau, D., D. Gold, H. Selawry, J. Moore, A. Franzusoff, and R. C. Duke. 1995. A role of CD95 ligand in preventing graft rejection. Nature 377:630.
7. Griffith, T. S., T. Brunner, S. M. Fletcher, D. R. Green, and T. A. Ferguson. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270:1189.
8. Yonehara, S., A. Ishii, and M. Yonehara. 1989. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-down-regulated with the receptor of tumor necrosis factor. J. Exp. Med. 169:1747.
9. Trauth, B. C., C. Klas, A. M. Peters, J. S. Matzku, P. Möller, W. Falk, K.-M. Debatin, and P. H. Krammer. 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301.
10. Boldin, M. P., E. E. Varfolomeev, Z. Pancer, I. L. Mett, J. H. Camonis, and D. Wallach. 1995. A novel protein that interacts with the death domain of Fas/Apo-1 contains sequence motif related to the death domain. J. Biol. Chem. 270:7795.
11. Chinnaiyan, A. M., K. O'Rourke, M. Tewari, and V. M. Dixit. 1995. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81:505.
12. Dhein, J., H. Walczak, C. Baumler, K.-M. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1 (CD95) on T lymphocytes. Nature 373:438.
13. Brunner, T., R. J. Mogil, D. LaFace, N. J. Yoo, A. Mahoubi, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynch, C. F. Ware, and D. R. Green. 1995. Cell-autonomous Fas (CD95)/Fas ligand interaction mediates activation-induced apoptosis in T cell hybridomas. Nature 373:441.
14. Ju, S.-T., D. J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D. H. Sherr, B. Z. Stanger, and A. Marshak-Rothstein. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444.
15. Singer, G. G., and A. K. Abbas. 1994. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365.
16. Andrews, B. S., R. A. Eisenberg, A. N. Theotilopoulos, S. Izui, C. B. Wilson, P. J. McConahey, E. D. Murphy, J. B. Roths, and F. J. Dixon. 1978. Spontaneous murine lupus-like syndromes. J. Exp. Med. 148:1198.
17. Roths, J. B., E. D. Murphy, and E. M. Eicher. 1984. A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice. J. Exp. Med. 159:1.
18. cg, that complements the gld gene in induction of lymphadenopathy in the mouse. J. Exp. Med. 171:519.
19. Fisher, G. H., F. J. Rosenberg, S. E. Straus, J. K. Dale, L. A. Middelton, A. Y. Lin, W. Strober, M. J. Lenardo, and J. M. Puck. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 31:935.
20. Rieux-Laucat, F., F. Le Deist, C. Hivroz, I. A. Roberts, K.-M. Debatin, A. Fischer, and J. P. de Villarty. 1995. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347.
21. Wu, J., J. Wilson, J. He, L. Xiang, P. H. Schur, and J. D. Mountz. 1996. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J. Clin. Invest. 98:1107.
22. Clevers, H., B. Alarcon, T. Wileman, and C. Terhost. 1988. The T cell receptor/ CD3 complex: a dynamic protein ensemble. Annu. Rev. Immunol. 6:629.
23. Gonzalez-Garcia, A., L. Borlado-R., E. Leonardo, I. Mérida, A. Martinez-C., and A. C. Carrera. 1997. Lck is necessary and sufficient for Fas-ligand expression and apoptotic cell death in mature cycling T cells. J. Immunol. 158:4104.
24. Eischen, C. M., B. L. Williams, W. Zhang, L. E. Samelson, D. H. Lynch, R. T. Abraham, and P. J. Leibson. 1997. Zap70 tyrosine kinase is required for the up-regulation of Fas ligand in activation-induced T cell apoptosis. J. Immunol. 159:1135.
25. Latinis, K. M., L. L. Carr, E. J. Peterson, L. A. Norian, S. L. Eliason, and G. A. Koretzky. 1997. Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events. J. Immunol. 158:4602.
26. Latinis, K. M., L. A. Norian, S. L Eliason, and G. A. Koretzky. 1997. Two NFAT transcriptional factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J. Biol. Chem. 272:31427.
27. Mittelstadt, P. R., and J. D. Ashwell. 1998. Cyclosporin A-sensitive transcription factor Egr-3 regulates Fas ligand expression. Mol. Cell. Biol. 18:3744.
28. Mittelstadt, P. R., and J. D. Ashwell. 1999. Role of Egr-2 in up-regulation of Fas ligand in normal T cells and aberrant double-negative lpr and gld T cells. J. Biol. Chem. 274:3222.
29. Matsui, K., A. Fine, B. Zhu, A. Marshak-Rothstein, and S.-T. Ju. 1998. Identification of two NF-κB sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma. J. Immunol. 161:3469.
30. Kasibhatla, S., L. Genestier, and D. R. Green. 1999. Regulation of Fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor κB. J. Biol. Chem. 274:987.
31. Faris, M., K. M. Latinis, S. Kempiak, G. A. Koretzky, and A. Nel. 1998. Stress-induced Fas ligand expression in T cells is mediated through MEK kinase 1-regulated response element in the Fas ligand promoter. Mol. Cell. Biol. 18:5414.
32. Kasibhatla, S., T. Brunner, L. Genestier, F. Echeverri, A. Mahboubi, and D. R. Green. 1998. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1, Mol. Cell 1:543.
33. Cui, H., M. El-Khatib, D. H. Sherr, R. Ettinger, M.-S. Sy, A. Marshak-Rothstein, and S.-T. Ju. 1996. Characterization of lpr-derived T cell hybridomas: Fas-deficient hybridomas are deathless, growth-arrested, and cytotoxic upon activation. Cell. Immunol. 167:302.
34. Gasahler, A. L., S. Swaminathan, and V. P. Sukhatme. 1993. A novel repression module, and extensive activation domain, and a bipartite nuclear localization signal defined in the immediate-early transcription factor Egr-1. Mol. Cell. Biol. 13:4556.
35. Chavrier, P., C. Vesque, B. Galliot, M. Vigneron, P. Dollé, D. Duboule, and P. Charnay. 1990. The segment specific gene Krox-20 encodes a transcription factor with binding sites in the promoter region of the Hox-1.4 gene. EMBO J. 9:1209.
36. Matsui, K., S. Omura, H. Cui, S. L. Schauer, G. E. Sonenshein, and S.-T. Ju. 1997. Proteasome regulation of Fas ligand cytotoxicity. Eur. J. Immunol. 27:2269.
37. Maxam, A. M., and W. Gilbert. 1977. A new method for sequencing DNA. Proc. Natl. Acad. Sci. USA 74:560.
38. Zhang, J., K. Miranda, B.-Y. Ma, and A. Fine. 1999. Molecular characterization of the mouse Fas ligand promoter in airway epithelial cells. Biochim. Biophys. Acta 93347:1.
39. Holtz-Heppelmann, C. J., A. Algeciras, A. D. Badley, and C. V. Paya. 1998. Transcriptional regulation of the human FasL promoter-enhancer region. J. Biol. Chem. 273:4416.
40. Xiao, S., K. Matsui, A. Fine, B. Bangmin, A. Marshak-Rothstein, R. L. Widom, and S.-T. Ju. 1999. FasL promoter activation by IL-2 through SP1 and NFAT but not Egr-2 and Egr-3. Eur. J. Immunol. 29:3456.
41. Du, W., D. Thanos, and T. Maniatis. 1993. Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements. Cell 74:887.
42. Stein, B., A. S. Baldwin Jr., D. W. Ballard, W. C. Greene, P. Angel, and P. Herrlich. 1993. Cross-coupling of the NF-κB and Fos/Jun transcription factors induces potentiated biological functions. EMBO J. 12:3879.
43. Tsuboi, A., M. Muramatsu, A. Tsutsumi, K. Arai, and N. Arai. 1994. Calcineurin activates transcription from the GM-CSF promoter in synergy with either protein kinase C or NF-κB/AP-1 in T cells. Biochem. Biophys. Res. Commun. 199:1064.
44. Gupta, S., D. Campbell, B. Dérijard, and R. J. Davis. 1995. Transcription factor ATF-2 regulation by JNK signal pathway. Science 267:389.
45. Yao, J., N. Mackman, T. S. Edgington, and S.-T. Fan. 1997. Lipopolysaccharide induction of the tumor necrosis factor-α promoter in human monocytic cells. J. Biol. Chem. 272:17795.
46. Martin, T., P. M. Cardarelli, G. C. N. Parry, K. A. Felts, and R. R. Cobb. 1997. Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-κB and AP-1. Eur. J. Immunol. 27:1091.
47. Thomas, R. S., M. J. Tymms, L. H. McKinlay, M. F. Shannon, A. Seth, and I. Kola. 1997. ETSI, NF-κB and API synergistically transactivate the human GM-CSF promoter. Oncogene 14:2845.
48. D'Adamio, F., O. Zollo, R. Moraca, E. Ayroldi, S. Bruscoli, A. Bartoli, L. Cannarile, G. Migliorati, and C. Riccardi. 1997. A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity 7:803.
49. Cogswell, P. C., M. W. Mayo, and A. S. Baldwin. 1997. Involvement of Egr-1/ Re1A synergy in distinguishing T cell activation from tumor necrosis factor-α-induced NF-κB1 transcription. J. Exp. Med. 185:491.
50. He, Y.-W., M. L. Deftos, E. W. Ojala, and M. J. Bevan. 1998. RORγ1, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells. Immunity 9:797.
51. Li-Weber, M., O. Laur, A. Hekele, J. Coy, H. Walczak, and P. H. Krammer. 1998. A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential for responsiveness to TCR-mediated activation. Eur. J. Immunol. 28:2373.